A Prospective Observational Registry of Patients Treated With LUPKYNIS® (Voclosporin) in the US
A Prospective Observational Registry of Patients Treated With LUPKYNIS® (Voclosporin) in the US
This registry is an observational study designed to assess the utilization and effectiveness of LUPKYNIS in adult patients with lupus nephritis (LN) in the United States (US).
This registry is an observational study designed to assess the utilization and effectiveness of LUPKYNIS in patients with lupus nephritis (LN) in the United States (US). This registry is intended to benefit and support interests of patients, clinicians, regulatory bodies, payers, and industry by obtaining longitudinal data on LUPKYNIS.
Inclusion Criteria:
Exclusion Criteria:
- Off-label use (Use of LUPKYNIS outside of the FDA-approved US Prescribing Information)